Concepedia

G. Durand‐Cavagna

GD

9

Publications

225

Citations

9

H-Index

1988

Active since

Affiliations

MSD (France)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

United States Military Academy

G. Durand‐Cavagna is an author at MSD (France) specializing in medicine, pharmacology, and urology.

Top concepts

Publications per year

1988–1999

9

Publications

9

Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

P. H. Berry, J. S. Macdonald, A W Alberts et al. · PubMed · 1988 · 41 citations · Full text

Spontaneous retinal changes in Sprague Dawley rats.

Marie-Françoise Hubert, J. Gillet, G. Durand‐Cavagna · PubMed · 1994 · 33 citations

, , +17

Evaluation of lymphocyte proliferation by immunohistochemistry in the local lymph node assay

Christine Boussiquet-Leroux, G. Durand‐Cavagna, K. Herlin et al. · Journal of Applied Toxicology · 1995 · 25 citations

Corneal toxicity studies in rabbits and dogs with hydroxyethyl cellulose and benzalkonium chloride

G. Durand‐Cavagna · Fundamental and Applied Toxicology · 1989 · 25 citations

, , +7

Dorzolamide, a 40-year wait. From an oral to a topical carbonic anhydrase inhibitor for the treatment of glaucoma.

G. S. PONTICELLO, Michael F. Sugrue, Bernard Plazonnet et al. · PubMed · 1998 · 25 citations

, , +12

Rows per page

1–5 of 9